Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bayer reveals antiinflammatory PDE4 inhibitors in patent literature

Aug. 10, 1999

Medeva acquires additional European rights to ML Laboratories' MDPI device

Aug. 10, 1999

Novel PAF antagonist CPR-3005 claimed in patent literature by Clarion

Aug. 9, 1999

Novel cell adhesion inhibitors prepared by Rhone-Poulenc Rorer

Aug. 6, 1999

Discovery Laboratories begins phase II tyloxapol trial in cystic fibrosis

Aug. 6, 1999

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

Aug. 3, 1999

International patent recently published covering AstraZeneca PKC inhibitors

July 28, 1999

Heterocyclic compounds as potent and selective NK2 antagonists

July 28, 1999

BM-113: pharmacokinetics and metabolism in rats following oral and intravenous dosing

July 27, 1999

Benzazepines synthesized at Zambon useful as antiallergic/antiinflammatory agents

July 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...